Fast-grow­ing Shang­hai Phar­ma to plant foot in San Diego, hunt­ing deals in US and Eu­rope

A mul­ti-bil­lion dol­lar Chi­nese phar­ma con­glom­er­ate, blessed with mu­nic­i­pal gov­ern­ment back­ing, is spread­ing its wings to the US and Eu­rope with eyes on R&D, man­u­fac­tur­ing and dis­tri­b­u­tion.

The com­pa­ny, called Shang­hai Phar­ma, is hunt­ing for Amer­i­can cor­po­ra­tions and re­search in­sti­tutes it can part­ner with and ac­quire Chi­na rights from to bol­ster its dis­tri­b­u­tion busi­ness (which re­cent­ly got a boost with the $557 mil­lion ac­qui­si­tion of Car­di­nal Health’s Chi­na unit).

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER